Botanical drugs: Challenges and opportunities. Contribution to Linnaeus Memorial Symposium 2007

Life Sciences

Volumn 82, Issue 9-10, 2008, Pages 445-449

  Liu, Yixuan ^a   Wang, Ming Wei ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Drug; Herb; Medicine; Natural; Remedy

Indexed keywords

GREEN TEA EXTRACT; HERBACEOUS AGENT; MINERAL; NATURAL PRODUCT; PLANT EXTRACT; POLYPHENON E; UNCLASSIFIED DRUG; VEREGEN; VITAMIN;

ALTERNATIVE MEDICINE; ALZHEIMER DISEASE; BOTANY; CONDYLOMA ACUMINATUM; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; EUROPE; HEALTH CARE; HERBAL MEDICINE; MEDICINAL PLANT; METABOLIC SYNDROME X; PHARMACEUTICAL CARE; PRESCRIPTION; REVIEW; SCHIZOPHRENIA; UNITED STATES;

DRUG INDUSTRY; HUMANS; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL;

EID: 39149106123     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.11.007     Document Type: Review

References (36)

1. Australian Government Department of Health and Ageing - Therapeutic Goods Administration. The Regulation of Complementary Medicines in Australia: an Overview, Symonston, Australia (2006). http://www.tga.gov.au/cm/cmreg-aust.htm Apr. 24 (http://www.tga.gov.au/cm/cmreg-aust.htm)
2. Balunas M.J., and Kinghorn A.D. Drug discovery from medicinal plants. Life Sciences 78 (2005) 431-441
3. Bensoussan A., and Lewith G.T. Complementary medicine research in Australia: a strategy for the future. The Medical Journal of Australia 181 (2004) 331-333
4. Cardellina J.H. Challenges and opportunities confronting the botanical dietary supplement industry. Journal of Natural Products 65 (2002) 1073-1084
5. Center for Drug Evaluation and Research. Office of Drug Evaluation I. Food and Drug Administration, U.S (2006). http://www.fda.gov/Cder/Offices July 6 (http://www.fda.gov/Cder/Offices)
6. China Chamber of Commerce for Import & Export of Medicines & Health Products. Brief on TCM market in Singapore. Research & Information on Traditional Chinese Medicine 5 (2003) 60-61
7. Dubey N.K., Kumar R., and Tripathi P. Global promotion of herbal medicine: India's opportunity. Current Science 86 (2004) 37-41
8. Fan X.H., Cheng Y.Y., Ye Z.L., Lin R.C., and Qian Z.Z. Multiple chromatographic fingerprinting and its application to the quality control of herbal medicines. Analytica Chimica Acta 555 (2006) 217-224
9. Goldman P. Herbal medicines today and the roots of modern pharmacology. Annals of Internal Medicine 135 (2001) 594-600
10. Herb Society. A Guide to the EU Traditional Herbal Medicines Directive and its Possible Implications (2004). http://www.herbsociety.org.uk/legislation.htm (http://www.herbsociety.org.uk/legislation.htm)
11. Jachak S.M., and Saklani A. Challenges and opportunities in drug discovery from plant. Current Science 92 (2007) 1251-1257
12. Jia W., Liu P., Jiang J., Chen M., and Zhao L. Application of metabonomics in complicated theory system research of traditional Chinese Medicine. China Journal of Chinese Materia Medica 31 (2006) 621-624
13. Kinghorn A.D. Pharmacognosy in the 21st century. Journal of Pharmacy and Pharmacology 53 (2001) 135-148
14. Lee K.H. Research and discovery trends of Chinese medicine in the new century. Journal of Chinese Medicine 15 (2004) 151-160
15. Li F., Xiong Z., Lu X., Win F., and Li X. Strategy of quality control for traditional Chinese medicines and chromatographic technology. Chinese Journal of Chromatography 24 (2006) 537-544
16. Liu Y., and Yang L. Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics. Journal of Zhejiang University 7 (2006) 99-106
17. The UK Medicines Healthcare Products Regulatory Agency (MHRA). MHRA Grants Landmark Registration for Traditional Herbal Medicine (2006). http://www.mhra.gov.uk/home November 8 (http://www.mhra.gov.uk/home)
18. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 70 (2007) 461-477
19. Normile D. The new face of traditional Chinese medicine. Science 299 (2003) 188-190
20. Patwardhan B., and Gautam M. Botanical immunodrugs: scope and opportunities. Drug Discovery Today 10 (2005) 495-502
21. Patwardhan B., Warude D., Pushpangadan P., and Bhatt N. Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-based Complementary and Alternative Medicine 2 (2005) 465-474
22. Qiu J. A culture in the balance. Nature 448 (2007) 126-128
23. Raskin I., Ribnicky D.M., Komarnytsky S., Ilic N., Poulev A., Borisjuk N., Brinker A., Moreno D.A., Ripoll C., Yakoby N., O'Neal J.M., Cornwell T., Pastor I., and Fridlender B. Plants and human health in the twenty-first century. Trends in Biotechnology 20 (2002) 522-531
24. Republic of Singapore Government Gazette Acts Supplement. Health Products Act 2007 (2007). http://statutes.agc.gov.sg (http://statutes.agc.gov.sg)
25. Simmonds M. Novel drugs from botanical sources. Drug Discovery Today 8 (2003) 721-722
26. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry Botanical Drug Products (2004). http://www.fda.gov/cder/guidance (http://www.fda.gov/cder/guidance)
27. Voigt K. Our look at global burgeoning Asian herbal industry. The Wall Street Journal (2006) June 11
28. Wang Z.G., and Ren J. Current status and future direction of Chinese herbal medicine. Trends in Pharmacological Sciences 23 (2002) 347-348
29. Wang Z., Du Q., and Wang F. Microarray analysis of gene expression on herbal glycoside recipes improving deficient ability of spatial learning memory in ischemic mice. Journal of Neurochemistry 88 (2004) 1406-1415
30. Wang M.W., Hao X.J., and Chen K.X. Biological screening of natural products and drug innovation in China. Philosophical Transactions of the Royal Society B 362 (2007) 1093-1105
31. World Health Organization. Report of the Inter-Regional Workshop on Intellectual Property Rights in the Context of Traditional Medicine, Bangkok, Thailand (2000). http://www.who/int/medicines/library/trm/who.edu.trm-2001-I/who-edutrm-2 001-1.pdf Dec. 6-8 (http://www.who/int/medicines/library/trm/who.edu.trm-2001-I/who-edutrm- 2001-1.pdf)
32. Yee S.K., Chu S.S., Xu Y.M., and Choo P.L. Regulatory control of Chinese proprietary medicines in Singapore. Health Policy 71 (2005) 133-149
33. Yuan R., and Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Pharmacology & Therapeutics 86 (2000) 191-198
34. Zamiska N. Is a shotgun better than a silver bullet?. The Wall Street Journal (2007) Mar. 2
35. Zhang J., Wang Q., and Wang Z. Systems biology and traditional Chinese medicine (TCM) modernization. China Journal of Chinese Materia Medica 30 (2005) 1725-1727
36. Zhou M., Liu P., Jia W., Zhao A., Qiu M., Qiu Y., and Su M. Evaluation of therapeutic effects of TCM based on metabolic variations. World Science and Technology - Modernization of Traditional Chinese Medicine and Materia Medica 8 (2006) 113-119